Laurus Labs Limited
LAURUSLABS
Classement en actions
#1744
Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited,... Established in 2005 and headquartered in Hyderabad, India, Laurus Labs Limited, along with its subsidiaries, operates as a diversified global pharmaceutical company. It focuses on the research, manufacturing, and international distribution of a broad spectrum of medicines and active pharmaceutical ingredients (APIs). The company's API and advanced intermediate offerings cover key therapeutic domains such as anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C. Additionally, Laurus Labs develops and produces oral solid dosage forms targeting ARV, antidiabetic, cardiovascular, PPI, and central nervous system (CNS) conditions. Beyond its proprietary products, the firm extends its expertise through contract development and manufacturing services for other pharmaceutical enterprises. It also supplies specialized ingredients vital for nutraceutical, dietary supplement, and cosmeceutical applications. Furthermore, Laurus Labs is at the forefront of innovation, engineering novel enzymatic solutions for industrial biotechnology, and providing animal-origin-free recombinant proteins and enzymes for biopharmaceutical use, alongside offering a range of business support services within the pharmaceutical industry.
Prix de l'action
$22.80
Capitalisation boursière
$12.32B
Changement (1 jour)
0.36%
Changement (1 an)
122.99%
Pays
IN
Échange Laurus Labs Limited (LAURUSLABS)
Catégorie
Healthcare
EPS pour Laurus Labs Limited (LAURUSLABS)
EPS au June 2026 TTM : $0.22
Selon les derniers rapports financiers et le cours de l'action de Laurus Labs Limited, l’EPS actuel de la société (TTM) est de $0.22. À la fin de 2024, la société avait un EPS de $0.04 une diminution par rapport à celui de 2023, qui était de $0.18.
Historique de l'EPS de Laurus Labs Limited de 2013 à 2026
EPS à la fin de chaque année
| Année | EPS | Changez |
|---|---|---|
| 2026 (TTM) | $0.22 | 179.38% |
| 2025 | $0.08 | 117.93% |
| 2024 | $0.04 | -80.03% |
| 2023 | $0.18 | -11.96% |
| 2022 | $0.20 | -19.02% |
| 2021 | $0.25 | 294.34% |
| 2020 | $0.06 | 149.41% |
| 2019 | $0.03 | -47.64% |
| 2018 | $0.05 | -24.02% |
| 2017 | $0.06 | -0.62% |
| 2016 | $0.06 | 82.20% |
| 2015 | $0.04 | -4.07% |
| 2014 | $0.04 | -30.64% |
| 2013 | $0.05 | 0.00% |
EPS pour des entreprises ou concurrents similaires
| Entreprise | EPS | Différence d’EPS | Pays |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 148.90% |
IN
|
